Mouse Toll Like Receptor 3 (TLR3) CLIA Kit

845€ (96 tests)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Mouse Toll Like Receptor 3 (TLR3) CLIA Kit
category
CLIA Kits
provider
Abbexa
reference
abx190582
tested applications
CLIA
Description
Mouse Toll Like Receptor 3 (TLR3) Chemiluminescent Immunoassay (CLIA) Kit is a Sandwich Chemiluminescent Immunoassay (CLIA) Kit for use with Tissue homogenates, cell lysates, cell culture supernates and other biological fluids.
Documents del producto
Instrucciones
Data sheet
Product specifications
Category | CLIA Kits |
Immunogen Target | Toll Like Receptor 3 (TLR3) |
Reactivity | Mouse |
Detection Method | Chemiluminescent |
Assay Data | Quantitative |
Assay Type | Sandwich |
Test Range | 5.49 pg/ml - 4000 pg/ml |
Sensitivity | < 1.93 pg/ml |
Recommended Dilution | Optimal dilutions/concentrations should be determined by the end user. |
Size 1 | 96 tests |
Size 2 | 5 × 96 tests |
Size 3 | 10 × 96 tests |
Form | Lyophilized |
Tested Applications | CLIA |
Sample Type | Tissue homogenates, cell lysates, cell culture supernatants and other biological fluids. |
Availability | Shipped within 5-7 working days. |
Storage | Shipped at 4 °C. Upon receipt, store the kit according to the storage instruction in the kit's manual. |
Dry Ice | No |
Alias | Toll-like receptor 3,CD283,IIAE2,IMD83, |
Background | CLIA Kits TLR3 |
Status | RUO |
Note | The validity for this kit is at least 6 months. Up to 12 months validity can be provided on request. This product is for research use only. The range and sensitivity is subject to change. Please contact us for the latest product information. For accurate results, sample concentrations must be diluted to mid-range of the kit. If you require a specific range, please contact us in advance or write your request in your order comments. Please note that our ELISA and CLIA kits are optimised for detection of native samples, rather than recombinant proteins. We are unable to guarantee detection of recombinant proteins, as they may have different sequences or tertiary structures to the native protein. |
Descripción
Toll-like receptor 3 (TLR3) is a crucial component of the innate immune system and plays a significant role in the detection of viral double-stranded RNA (dsRNA), a molecular pattern associated with viral infections. Unlike other TLRs, TLR3 is predominantly responsible for recognizing viral RNA rather than bacterial or fungal components, making it particularly important in antiviral immunity. TLR3 is expressed not only in immune cells like macrophages and dendritic cells but also in non-immune cells, such as epithelial cells and fibroblasts, which are often the first to encounter viral pathogens. Upon detecting dsRNA, TLR3 activates pathways leading to type I interferon production and pro-inflammatory cytokine release, which are essential for controlling viral infections and coordinating subsequent adaptive immune responses. TLR3 is primarily located in the endosomal membranes within cells, allowing it to recognize viral RNA that enters cells through phagocytosis or endocytosis. Its role in initiating antiviral responses makes it a subject of interest for immunological research and therapeutic interventions, particularly in viral diseases, immune disorders, and even cancer. TLR3 signaling pathways and its effects on cell function have also highlighted its involvement in other disease processes, where aberrant TLR3 activation may contribute to inflammation and tissue damage. Its unique function in antiviral immunity and role in a broader range of diseases positions TLR3 as a promising target for therapeutic modulation.
Related Products

Human TLR3 (Toll-like receptor 3) ELISA Kit
Ver Producto
TLR3 antibody
Key component of innate and adaptive immunity. TLRs(Toll-like receptors) control host immune response against pathogens through recognition of molecular patterns specific to microorganisms. TLR3 is a nucleotide-sensing TLR which is activated by double-stranded RNA, a sign of viral infection. Acts via the adapter TRIF/TICAM1, leading to NF-kappa-B activation, IRF3 nuclear translocation, cytokine secretion and the inflammatory response.
Ver Producto